A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer

References

• EngelCFischerCBreast cancer risks and risk prediction modelsBreast Care201510171225960719
   PubMed Web of Science ®Google Scholar
• GreenupRBuchananALorizioWPrevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohortAnn Surg Oncol201320103254325823975317
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkGenetic/familial high-risk assessment: breast and ovarian. Version 1.2018, October 3, 2017NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)2017 Available from: https://www.nccn.org/Accessed December 15, 2017
   Google Scholar
• Paluch-ShimonSCardosoFSessaCPrevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screeningAnn Oncol201627Suppl 5v103v11027664246
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence [homepage on the Internet]Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancerNICE clinical guideline CG1642013 Available from: nice.org.uk/guidance/cg164Accessed November 30, 2017
   Google Scholar
• CragunDWeidnerALewisCRacial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivorsCancer2017123132497250528182268
   PubMed Web of Science ®Google Scholar
• LittonJKRugoHSEttlJTalazoparib in patients with advanced breast cancer and a germline BRCA mutationN Engl J Med2018379875376330110579
   PubMed Web of Science ®Google Scholar
• RobsonMImSASenkusEOlaparib for metastatic breast cancer in patients with a germline BRCA mutationN Engl J Med2017377652353328578601
   PubMed Web of Science ®Google Scholar
• TuttAToveyHCheangMCUCarboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT trialNat Med201824562863729713086
   PubMed Web of Science ®Google Scholar
• LivraghiLGarberJEPARP inhibitors in the management of breast cancer: current data and future prospectsBMC Med201513118826268938
   PubMed Web of Science ®Google Scholar
• BellcrossCAKolorKGoddardKACoatesRJReyesMKhouryMJAwareness and utilization of BRCA1/2 testing among U.S. primary care physiciansAm J Prev Med2011401616621146769
   PubMed Web of Science ®Google Scholar
• MarzuilloCDe VitoCBocciaSKnowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancerPrev Med201357547748223827720
   PubMed Web of Science ®Google Scholar
• MarzuilloCDe VitoCD’AddarioMAre public health professionals prepared for public health genomics? A cross-sectional survey in ItalyBMC Health Serv Res201414123924885316
   PubMedGoogle Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions [Internet]. Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from: http://handbook-5-1.cochrane.org/Accessed March 23, 2011
   Google Scholar
• Centre for Reviews and Dissemination [homepage on the Internet]Systematic Reviews: CRD’s guidance for undertaking reviews in health care2009 Available from: http://www.york.ac.uk/inst/crd/SysRev/!SSL!/WebHelp/SysRev3.htmAccessed December 1, 2018
   Google Scholar
• KmBMBrowmanGPAgree II: advancing Guideline Development, reporting and evaluation in healthcareCAMJ201018218E839E842
   PubMed Web of Science ®Google Scholar
• LeeCHDershawDDKopansDBreast cancer screening with imaging: recommendations from the Society of breast imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancerJ Am Coll Radiol201071182720129267
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network [Internet]Breast Cancer Risk Reduction: NCCN Evidence Blocks Version 1.2018, February 2, 2018Fort Washington (PA)NCCN2018
   Google Scholar
• Cancer Australia [Internet]Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation2014 Available from: http://guidelines.canceraustralia.gov.au/guidelines/gene_mutation/index.phpAccessed January 5, 2018
   Google Scholar
• TairaNAraiMIkedaMThe Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 editionBreast Cancer201623334335626873619
   PubMed Web of Science ®Google Scholar
• Paluch-ShimonSPaganiOPartridgeAHESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)Breast20173520321728822332
   PubMed Web of Science ®Google Scholar
• CardosoFCostaASenkusE3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)Ann Oncol201728123111313328327998
   PubMed Web of Science ®Google Scholar
• KreienbergRAlbertU-SFollmannMKoppIKühnTWöckelAInterdisciplinary GoR level III guidelines for the diagnosis, therapy and follow-up care of breast cancerGeburtshilfe Frauenheilkd201373655658324771925
   PubMed Web of Science ®Google Scholar
• MainieroMBMoyLBaronPACR appropriateness criteria breast cancer screeningJ Am Coll Radiol20171411S383S39029101979
   PubMedGoogle Scholar
• Cancer Care Ontario [homepage on the Internet]Magnetic resonance imaging screening of women at high risk for breast cancer2012 Available from: https://www.cancercareontario.ca/en/file/17606/download?token=6D-cb8xwAccessed November 30, 2017
   Google Scholar
• Integraal Kankercentrum NederlandMammacarcinoomNational evidence based guideline2012 Available from: http://www.oncoline.nl/mammacarcinoomAccessed November 29, 2017
   Google Scholar
• National Cancer Control Programme [Internet]Diagnosis, staging and treatment of patients with breast cancer: national clinical guideline no 72015 Available from: https://www.hse.ie/eng/services/list/5/cancer/profinfo/guidelines/breast/breastguideline.pdfAccessed November 30, 2017
   Google Scholar
• WrightFCLook HongNJQuanMLIndications for contralateral prophylactic mastectomy: a consensus statement using modified Delphi methodologyAnn Surg2018267227127928594745
   PubMed Web of Science ®Google Scholar
• London Cancer Alliance [Internet]LCA breast cancer clinical guidelines2013 (updated March 2016). Available from: http://rmpartners.cancervanguard.nhs.uk/wp-content/uploads/2017/03/lca-breast-cancer-clinical-guidelines-october-2013-updated-march-2016-.pdfAccessed November 30, 2017
   Google Scholar
• National Comprehensive Cancer Network [Internet]Breast cancer screening and diagnosis (version 1.2017, June 2, 2017)NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines)2017 Available from: https://www.nccn.orgAccessed December 20, 2017
   Google Scholar
• National Comprehensive Cancer Network [Internet]Breast cancer (version 1.2018, March 20, 2018)2018209 Available from: https://www.nccn.org/Accessed April 10, 2018
   Google Scholar
• National Institute for Health and Care ExcellenceOlaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube ad peritoneal cancer after resposne to second-line or subsequent plantinum-based chemotherapy [Internet]2016 Available from: https://www.guideline.gov/summaries/downloadcontent/ngc-10895?contentType=pdfAccessed November 30, 2017
   Google Scholar
• RunowiczCDLeachCRHenryNLAmerican cancer Society/American Society of clinical oncology breast cancer survivorship care guidelineCA Cancer J Clin2016661437326641959
   PubMed Web of Science ®Google Scholar
• SenkusEKyriakidesSOhnoSPrimary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201526Suppl 5v8v3026314782
   PubMed Web of Science ®Google Scholar
• Toward Optimized Practice (TOP) Working Group for breast cancer screeningBreast cancer screening: clinical practice guideline2013 Available from: http://www.topalbertadoctors.org/download/243/breast_cancer_guideline.pdf?_20150423045720Accessed November 30, 2017
   Google Scholar
• HampelHBennettRLBuchananAPearlmanRWiesnerGLGuideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines CommitteeA practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessmentGenet Med2015171708725394175
   PubMed Web of Science ®Google Scholar
• RunowiczCDLeachCRHenryNLAmerican Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineJ Clin Oncol201634661163526644543
   PubMed Web of Science ®Google Scholar
• LancasterJMPowellCBChenLMRichardsonDLSGO Clinical Practice CommitteeSociety of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositionsGynecol Oncol201513613725238946
   PubMed Web of Science ®Google Scholar
• U.S. Preventive Services Task Force [Internet]Evidence summaryOther supporting document for BRCA-related cancer: risk assessment, genetic counseling, and genetic testing2013 Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testingAccessed December 5, 2017
   Google Scholar
• National Comprehensive Cancer Network [Internet]Breast cancer: NCCN evidence blocks (version 4.2017, February 9, 2018)2018 Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast_blocks.pdfAccessed February 16, 2018
   Google Scholar
• Arbeitsgemeinschaft Gynäkologische Onkologie E.V [Internet]Diagnosis and treatment of patients with primary and metastatic breast cancer2017 Available from: https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/2017-03/AGO_englisch/PDF_Gesamt-datei_englisch/Updated%20Guidelines_2017.pdfAccessed December 19, 2017
   Google Scholar
• LlortGChirivellaIMoralesRSEOM clinical guidelines in Hereditary Breast and ovarian cancerClin Transl Oncol2015171295696126669313
   PubMed Web of Science ®Google Scholar
• Healthcare Improvement Scotland [Internet]Familial breast cancer report2014 Available from: http://www.healthcareim-provementscotland.org/his/idoc.ashx?docid=47b6cdaa-175e-482b-a564-6d68860b6d20&version=-1Accessed November 30, 2017
   Google Scholar
• The Royal Marsden NHS Foundation Trust [Internet]Protocol 2: BRCA1 and BRCA2 mutation testing2017 Available from: https://d1ijoxngr27nfi.cloudfront.net/default-document-library/protocol-2-brca-mutation-testing.pdf?sfvrsn=0Accessed November 30, 2017
   Google Scholar
• The Royal Marsden NHS Foundation Trust [Internet]Protocol 1: management guidelines for unaffected women with a family history of breast and/or ovarian cancer2015 Available from: https://d1ijoxn-gr27nfi.cloudfront.net/research-divisions/protocol-1-mammographic-surveillance_20150209_v4.pdf?sfvrsn=2Accessed November 30, 2017
   Google Scholar
• The Royal Marsden NHS Foundation Trust [Internet]Protocol 3: BRCA mutation carrier guidelines2015 Available from: https://d1ijoxngr27nfi.cloudfront.net/research-divisions/protocol-3-brca-mutation-carrier-20150209-v4.pdf?sfvrsn=2Accessed November 30, 2017
   Google Scholar
• The Royal College of Radiologists Faculty of Clinical Radiology [Inter-net]Guidance on screening and symptomatic breast imaging20133rd ed Available from: https://www.rcr.ac.uk/system/files/publication/field_publication_files/BFCR(13)5_breast.pdfAccessed December 1, 2017
   Google Scholar
• American Society for Radiation OncologyAccelerated Partial Breast Irradiation: Update of an ASTRO Evidence-based Consensus StatementAlington (VA)Practical Radiation Oncology2017
   Google Scholar
• KatzSJWardKCHamiltonASGaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancerJ Clin Oncol201836121218122429528794
   PubMed Web of Science ®Google Scholar
• TungNMGarberJEBRCA1/2 testing: therapeutic implications for breast cancer managementBr J Cancer2018119214115229867226
   PubMed Web of Science ®Google Scholar
• DalyMBPilarskiRBerryMNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment. Breast and Ovarian, Version 2.2017J Natl Compar Canc Netw2017151920
   PubMed Web of Science ®Google Scholar
• ByrskiTHuzarskiTDentRPathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patientsBreast Cancer Res Treat2014147240140525129345
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network [Internet]Genetic/familial high-risk assessment: breast and ovarian. Version 2.2019, July 302018 Available from: https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfAccessed August 3, 2018
   Google Scholar
• E.V. AGODiagnosis and treatment of patients with primary and metastatic breast cancerTaufkirchenAGO2018 Available from: https://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/2018-03/EN/Gesamt_PDF_Englisch/Updated_Guidelines_2018.pdfAccessed January 18, 2018
   Google Scholar
• CardosoFSenkusECostaA4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Ann Oncol2018291634165730032243
   PubMed Web of Science ®Google Scholar
• Rizk C [Internet]Researchers Debate Merits of Population-Wide Genetic Testing at AARCNew YorkGenomeWeb2017 Available from: https://www.genomeweb.com/genetic-research/researchers-debate-merits-population-wide-genetic-testing-aacr#.W5wRSflKiUkAccessed June 26, 2018
   Google Scholar
• Gabai-KaparaELahadAKaufmanBPopulation-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2Proc Natl Acad Sci USA201411139142051421025192939
   PubMed Web of Science ®Google Scholar
• MetcalfeKAPollARoyerRScreening for founder mutations in BRCA1 and BRCA2 in unselected Jewish womenJ Clin Oncol201028338739120008623
   PubMed Web of Science ®Google Scholar
• KangHHWilliamsRLearyJEvaluation of models to predict BRCA germline mutationsBr J Cancer200695791492017016486
   PubMed Web of Science ®Google Scholar
• FebbraroTRobisonKWilburJSAdherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionalsGynecol Oncol2015138110911425933682
   PubMed Web of Science ®Google Scholar
• NilssonMPWinterCKristofferssonUEfficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancerFam Cancer201716218719328120249
   PubMed Web of Science ®Google Scholar
• TungNLinNUKiddJFrequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancerJ Clin Oncol201634131460146826976419
   PubMed Web of Science ®Google Scholar
• ManchandaRPatelSGordeevVSCost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population womenJ Natl Cancer Inst2018110771472529361001
   PubMedGoogle Scholar
• CampbellIGRowleySDevereuxLPopulation genetic testing for breast cancer susceptibilityPaper presented at: San Antonio Breast Cancer Symposium5–9 December 2017San Antonio (TX)
   Google Scholar
• TolandAEFormanACouchFJClinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practicesNPJ Genom Med201831729479477
   PubMedGoogle Scholar
• KurianAWWardKCHamiltonASUptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancerJAMA Oncol201848106629801090
   PubMed Web of Science ®Google Scholar
• D’AndreaEMarzuilloCDe VitoCWhich BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluationsGenet Med201618121171118027906166
   PubMed Web of Science ®Google Scholar
• SchullySDBenedictoCBGillandersEMWangSSKhouryMJTranslational research in cancer genetics: the road less traveledPublic Health Genomics20111411820051673
   PubMed Web of Science ®Google Scholar
• D’AndreaELagerbergTDe VitoCPatient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophiliaEur J Hum Genet201826451852629374276
   PubMed Web of Science ®Google Scholar
• GuyattGHOxmanADSchunemannHJTugwellPKnottnerusAGRADE guidelines: a new series of articles in the Journal of Clinical EpidemiologyJ Clin Epidemiol201164438038221185693
   PubMed Web of Science ®Google Scholar
• ChenYYangKMarušićAA reporting tool for practice guidelines in health care: the RIGHT statementAnn Intern Med2017166212813227893062
   PubMed Web of Science ®Google Scholar